The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis von van Velzen, A.J, Uges, J.W.F, Le Brun, P.P.H, Shahbabai, P, Touw, D.J, Heijerman, H.G.M

Volltext

WS14.3 Tobramycin nebulization with the I-neb® in children with cystic fibrosis (TONI study): pharmacokinetics and safety von van Velzen, A.J, Uges, J.W.F, Heijerman, H.G.M, Arets, H.G, Nuijsink, M, van der Wiel-Kooij, E.C, van Maarseveen, E.M, van Zanten, G.A, Pullens, B, Touw, D.J, Janssens, H.M

Volltext

WS14.5 Influence of breathing pattern on pulmonary aerosol deposition in patients with cystic fibrosis (CF): a pharmacokinetic approach von Van Velzen, A.J, Uges, J.W.F, Le Brun, P.P.H, Shahbabai, P, Touw, D.J, Heijerman, H.G.M

Volltext

ePS04.7 Tobramycin nebulization with I-neb® in children with cystic fibrosis (TONI study): Pharmacokinetics and safety von van Velzen, A.J, Uges, J.W.F, Arets, H.G.M, Nuijsink, M, van der Wiel-Kooij, E.C, Pullens, B, Heijerman, H.G.M, Touw, D.J, Janssens, H.M

Volltext

197 Influence of inhalation mode on aerosol lung deposition in patients with cystic fibrosis PART 1: Pharmacokinetic data as representative of lung deposition von van Velzen, A.J, Shahbabai, P, Uges, J.W.F, Touw, D.J, Heijerman, H.G.M

Volltext